50
Participants
Start Date
March 1, 2026
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2027
GnRH antagonist
blockade of hormone production
Estradiol (E2)
Estrogen add-back in females
Testosterone
testosterone add-back in males
Anastrozole (Arimidex)
Prevention of testosterone conversion to estrogen in males
University of British Columbia - Okanagan, Kelowna
University of British Columbia
OTHER